{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:56:44Z","timestamp":1776329804017,"version":"3.50.1"},"reference-count":15,"publisher":"Baskent University","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.6002\/ect.2022.0298","type":"journal-issue","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T01:20:28Z","timestamp":1681953628000},"source":"Crossref","is-referenced-by-count":0,"title":[],"prefix":"10.6002","volume":"22","member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Hart A, Lentine KL, Smith JM, et al. OPTN\/SRTR 2019 Annual Data Report: Kidney. Am J Transplant. 2021;21 Suppl 2:21-137. doi:10.1111\/ajt.16502","DOI":"10.1111\/ajt.16502"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Muzaale AD, Massie AB, Wang MC, et al. Risk of end-stage renal disease following live kidney donation. JAMA. 2014;311(6):579-586. doi:10.1001\/jama.2013.285141","DOI":"10.1001\/jama.2013.285141"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Lentine KL, Kasiske BL, Levey AS, et al. KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors. Transplantation. 2017;101(8S Suppl 1):S1-S109. doi:10.1097\/TP.0000000000001769","DOI":"10.1097\/TP.0000000000001769"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Muzaale AD, Massie AB, Wang MC, et al. Risk of end-stage renal disease following live kidney donation. JAMA. 2014;311(6):579-586. doi:10.1001\/jama.2013.285141","DOI":"10.1001\/jama.2013.285141"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Engels EA, Fraser GE, Kasiske BL, et al. Cancer risk in living kidney donors. Am J Transplant. 2022;22(8):2006-2015. doi:10.1111\/ajt.17082","DOI":"10.1111\/ajt.17082"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Gupta NP, Albani JM, Novick AC, Sivaramakrishna B, Kumar R. Renal cell cancer in solitary kidney after donor nephrectomy. Urology. 2004;64(4):808-809. doi:10.1016\/j.urology.2004.05.015","DOI":"10.1016\/j.urology.2004.05.015"},{"key":"ref6","unstructured":"7. Richie JP. Definitive surgical management of renal cell carcinoma. In: Atkins MB, Chen W, eds. UptoDate. Updated May 11, 2021. Accessed August 29, 2022. https:\/\/www.uptodate.com\/contents\/definitive-surgical-management-of-renal-cell-carcinoma"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Pierorazio PM, Johnson MH, Patel HD, et al. Management of renal masses and localized renal cancer: systematic review and meta-analysis. J Urol. 2016;196(4):989-999. doi:10.1016\/j.juro.2016.04.081","DOI":"10.1016\/j.juro.2016.04.081"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Lowrance WT, Ordonez J, Udaltsova N, Russo P, Go AS. CKD and the risk of incident cancer. J Am Soc Nephrol. 2014;25(10):2327-2334. doi:10.1681\/ASN.2013060604","DOI":"10.1681\/ASN.2013060604"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Davis CL, Cooper M. The state of U.S. living kidney donors. Clin J Am Soc Nephrol. 2010;5(10):1873-1880. doi:10.2215\/CJN.01510210","DOI":"10.2215\/CJN.01510210"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Okamoto M, Akioka K, Nobori S, et al. Short- and long-term donor outcomes after kidney donation: analysis of 601 cases over a 35-year period at Japanese single center. Transplantation. 2009;87(3):419-423. doi:10.1097\/TP.0b013e318192dc95","DOI":"10.1097\/TP.0b013e318192dc95"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Lentine KL, Vijayan A, Xiao H, et al. Cancer diagnoses after living kidney donation: linking U.S. Registry data and administrative claims. Transplantation. 2012;94(2):139-144. doi:10.1097\/TP.0b013e318254757d","DOI":"10.1097\/TP.0b013e318254757d"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Kasiske BL, Anderson-Haag TL, Duprez DA, et al. A prospective controlled study of metabolic and physiologic effects of kidney donation suggests that donors retain stable kidney function over the first nine years. Kidney Int. 2020;98(1):168-175. doi:10.1016\/j.kint.2020.01.017","DOI":"10.1016\/j.kint.2020.01.017"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Sui Y, Zhao HL, Lee HM, et al. Renal carcinogenesis after uninephrectomy. Transl Oncol. 2009;2(4):258-263. doi:10.1593\/tlo.09142","DOI":"10.1593\/tlo.09142"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Kato S, Chmielewski M, Honda H, et al. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol. 2008;3(5):1526-1533. doi:10.2215\/CJN.00950208","DOI":"10.2215\/CJN.00950208"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T03:22:56Z","timestamp":1732504976000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ectrx.org\/detail\/archive\/2024\/22\/10\/0\/814\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.2022.0298","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10]]}}}